Selective LXR agonist DMHCA corrects retinal and bone marrow dysfunction in type 2 diabetes

标题
Selective LXR agonist DMHCA corrects retinal and bone marrow dysfunction in type 2 diabetes
作者
关键词
-
出版物
JCI Insight
Volume 5, Issue 13, Pages -
出版商
American Society for Clinical Investigation
发表日期
2020-07-08
DOI
10.1172/jci.insight.137230

向作者/读者发起求助以获取更多资源

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started